In contrast, stratification of this cohort by high Cav-1 and low MnSOD conferred a two-fold lower risk of death from the disease (OR = 0.545, 95% CI 0.354 – 0.839, p < 0.01), and sufficiently discriminated between healthy subjects and patients with invasive ductal carcinoma (OR = 0.203, 95% CI 0.127 – 0.324, p < 0.01, Table 2), together indicating that this molecular fingerprint may have prognostic value for risk stratification. The gene discussed is CAV1; the disease is invasive ductal breast carcinoma.